Cargando…
Biochemical Markers of Myocardial Damage
Heart diseases, especially coronary artery diseases (CAD), are the leading causes of morbidity and mortality in developed countries. Effective therapy is available to ensure patient survival and to prevent long term sequelae after an acute ischemic event caused by CAD, but appropriate therapy requir...
Autor principal: | Bodor, Geza S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Communications and Publications Division (CPD) of the IFCC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4975226/ https://www.ncbi.nlm.nih.gov/pubmed/27683523 |
Ejemplares similares
-
The Laboratory’s Role in Opioid Pain Medication Monitoring
por: Bodor, Geza S.
Publicado: (2012) -
Is endocan a biochemical marker for asymptomatic target organ damage in hypertensive patients?
por: Ağaç, Mustafa Tarık, et al.
Publicado: (2019) -
COVID-19 and treatment guided by biochemical and molecular diagnostic tests to reduce myocardial damage and cardiotoxicity
por: Eiras, Sonia, et al.
Publicado: (2020) -
Led Astray by Hemoglobin A1c: A Case of Misdiagnosis of Diabetes by Falsely Elevated Hemoglobin A1c
por: Chen, Jean, et al.
Publicado: (2016) -
The Search for Biochemical Markers
por: Anthenelli, Robert M., et al.
Publicado: (1995)